Neurology

The CGTLive Neurology specialty topic page houses video interviews with key opinion leaders in the field of neurology about the latest relevant FDA actions, clinical guideline updates, and clinical trial findings related to cell therapies, gene therapies, and engineered and regenerative medicines developed for neurologic disorders and diseases. It also contains up-to-date clinical news coverage in the field of gene and cell therapy for central nervous system disorders.

Latest News

Around the Helix: Cell and Gene Therapy Company Updates – February 12, 2025
Around the Helix: Cell and Gene Therapy Company Updates – February 12, 2025

February 12th 2025

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Paul Y. Song, MD, the chairman and chief executive officer of NKGen
NKGen’s Autologous NK Cell Therapy Troculeucel Fast Tracked for Alzheimer Disease

February 12th 2025

International Epilepsy Day 2025: Looking Back at Progress for Cell and Gene Therapy
International Epilepsy Day 2025: Looking Back at Progress for Cell and Gene Therapy

February 10th 2025

CGTLive®’s Weekly Rewind
CGTLive®’s Weekly Rewind – February 7, 2025

February 7th 2025

Around the Helix: Cell and Gene Therapy Company Updates – February 5, 2025
Around the Helix: Cell and Gene Therapy Company Updates – February 5, 2025

February 5th 2025

Video Interviews
Podcasts
ImmunoLogic
ImmunoLogic
Jonathan Parker, MD, PhD, an assistant professor of neurosurgery at Mayo Clinic Arizona

More News

© 2025 MJH Life Sciences

All rights reserved.